Rocket Pharmaceuticals, Inc. (RCKT)
2.18
-0.18
(-7.63%)
USD |
NASDAQ |
Oct 16, 16:00
2.21
+0.03
(+1.38%)
After-Hours: 20:00
Rocket Pharmaceuticals Net Income (TTM) : -17.25M for June 30, 2026
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -17.25M |
| March 31, 2026 | -209.38M |
| December 31, 2025 | -223.12M |
| September 30, 2025 | -240.91M |
| June 30, 2025 | -257.30M |
| March 31, 2025 | -258.03M |
| December 31, 2024 | -258.75M |
| September 30, 2024 | -258.08M |
| June 30, 2024 | -253.26M |
| March 31, 2024 | -249.31M |
| December 31, 2023 | -245.60M |
| September 30, 2023 | -252.66M |
| June 30, 2023 | -248.51M |
| March 31, 2023 | -237.22M |
| December 31, 2022 | -221.86M |
| September 30, 2022 | -199.39M |
| June 30, 2022 | -191.75M |
| March 31, 2022 | -171.87M |
| December 31, 2021 | -169.07M |
| September 30, 2021 | -185.74M |
| June 30, 2021 | -164.70M |
| March 31, 2021 | -155.22M |
| December 31, 2020 | -139.70M |
| September 30, 2020 | -98.64M |
| June 30, 2020 | -88.84M |
| Date | Value |
|---|---|
| March 31, 2020 | -82.48M |
| December 31, 2019 | -77.27M |
| September 30, 2019 | -84.73M |
| June 30, 2019 | -81.54M |
| March 31, 2019 | -78.63M |
| December 31, 2018 | -74.52M |
| September 30, 2018 | -53.85M |
| June 30, 2018 | -44.49M |
| March 31, 2018 | -32.05M |
| December 31, 2017 | -19.38M |
| September 30, 2017 | -25.70M |
| June 30, 2017 | -30.11M |
| March 31, 2017 | -35.46M |
| December 31, 2016 | -42.85M |
| September 30, 2016 | -38.05M |
| June 30, 2016 | -82.88M |
| March 31, 2016 | -76.59M |
| December 31, 2015 | -67.98M |
| September 30, 2015 | -61.96M |
| June 30, 2015 | -8.385M |
| March 31, 2015 | -8.845M |
| December 31, 2014 | -9.531M |
| September 30, 2014 | -9.354M |
| June 30, 2014 | -8.898M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Sarepta Therapeutics, Inc. | -266.10M |
| Intellia Therapeutics, Inc. | -399.98M |
| Beam Therapeutics, Inc. | -85.43M |
| Arrowhead Pharmaceuticals, Inc. | -272.12M |
| Oncolytics Biotech, Inc. | -30.07M |